Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

Cellular manufacturing can accommodate high product variety with shorter lead times and less complex scheduling. However, most extant research presents clustering solutions to hypothetical or ...

Cellular Origins agreed to collaborate with Immatics in utilizing Cellular Origins’ automated mobile robotic platform, Constellation ®, within certain parts of the company’s manufacturing processes.

Dynamic cellular manufacturing systems (DCMS) represent an evolution of traditional cellular manufacturing in which groups of machines and labour are organised into flexible cells that can be ...

TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to ...

B&B Manufacturing re-arranges machines into cells, some of which can be dedicated to one customer’s parts. While B&B Manufacturing Co. Inc discribes itself as a job shop, it seems to have the level of ...

This new furniture factory in Asia is still utilizing the old "Roman legion" method of plant layout of grouping like machines together. Cell manufacturing offers a potential competitive advantage to ...

Site will serve as company’s new headquarters and expands capacity and capabilities for induced pluripotent stem cell development and manufacturing New facility is part of a $200 million investment by ...

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...

A study has developed an innovative method that overcomes the limitations of traditional additive manufacturing (3D printing), significantly simplifying and accelerating the production of ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ...

A study led by the School of Engineering of the Hong Kong University of Science and Technology (HKUST) has developed an innovative method that overcomes the limitations of traditional additive ...